Daptomycin molecular structure

Daptomycin

Also known as: Cubicin, Cubicin RF, Dapcin, Daptomed, Daptomycin for Injection

CAS Number: 103060-53-3

Cyclic lipopeptide antibacterial

Pharmacopeia Standards

USPEPCP

Mechanism of Action

Daptomycin inserts its decanoyl lipid tail into the Gram-positive cytoplasmic membrane in a strictly calcium-dependent manner and then oligomerises to form membrane-spanning aggregates. These aggregates cause rapid potassium efflux, membrane depolarisation and arrest of DNA, RNA and protein synthesis, killing the cell without lysis. Pulmonary surfactant sequesters and inactivates the molecule, which is why it has no role in pneumonia.

Technical Specifications

Generic / INN NameDaptomycin
CAS Registry Number103060-53-3
Molecular FormulaC72H101N17O26
Molecular Weight1620.67 g/mol g/mol
Typical PurityNLT 95.0% daptomycin by HPLC on anhydrous basis; anhydro-daptomycin NMT 2.0%; endotoxin NMT 0.5 EU/mg
Storage ConditionsStore at -20 C or 2-8 C per supplier specification in sealed, light-protected containers under nitrogen; maintain cold chain in transit
Shelf Life24-36 months from date of manufacture under validated frozen or refrigerated storage
CategoryLipopeptides & Polypeptides

Specifications are indicative and intended for sourcing reference only. Always confirm against the supplier's Certificate of Analysis and the applicable pharmacopeial monograph before issuing a purchase specification.

Typical Applications

Lyophilised powder for intravenous injection and infusion for complicated skin and skin structure infections, Staphylococcus aureus bloodstream infection, right-sided infective endocarditis, and off-label bone and joint infection.

Manufacturers (0+)

View all →
No manufacturers listed yet. Register your company to appear here.